The drugmaker set the goal of carbon neutrality in its own operations by 2025 and in its supply chain by 2030. It plans on decreasing its emissions across its value chain by 35 percent, reducing its fuel and energy consumption and implementing renewable energy sources.
Novartis will also expand an initiative to increase access to medicine in lower-income countries. Additionally, it will boost an initiative to reach patients with leprosy, malaria, sickle cell disease and Chagas disease, with the goal of reaching 23 million patients by 2025.
More articles on pharmacy:
Westerly Hospital opens $4M pharmacy
13 exec moves affecting the pharma industry
Mylan recalls 2 drugs after label mix-up
articles on pharmacy:
78% of Americans think vaccine approval process is too politics-driven
Westerly Hospital opens $4M pharmacy
13 exec moves affecting the pharma industry
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
